Related Experiment Videos
Clinical findings in Pelizaeus-Merzbacher disease
Meredith R Golomb1, Laurence E Walsh, Karen S Carvalho
1Department of Neurology, Division of Pediatric Neurology, Indiana University School of Medicine, Indianapolis, IN, USA. mgolomb@iupui.edu
Journal of Child Neurology
|July 1, 2004
Summary
Pelizaeus-Merzbacher disease, a rare X-linked disorder, involves impaired myelination due to proteolipid protein 1 gene mutations. This study details clinical findings in affected boys and a carrier girl, highlighting common symptoms like nystagmus and speech difficulties.
Area of Science:
- Genetics
- Neurology
- Pediatrics
Background:
- Pelizaeus-Merzbacher disease (PMD) is a rare X-linked disorder.
- It results from mutations in the proteolipid protein 1 (PLP1) gene, affecting central nervous system myelination.
- Detailed clinical data for genetically confirmed pediatric cases are limited.
Purpose of the Study:
- To describe the clinical characteristics of children with genetically confirmed PMD.
- To correlate genotype with phenotype in a cohort of PMD patients.
- To identify common presenting symptoms and associated complications.
Main Methods:
- Retrospective review of medical records for 10 boys and 1 symptomatic carrier girl with PMD.
- Genetic confirmation of PLP1 gene mutations (duplications, point mutations, deletions).
- Analysis of clinical findings, including neurological signs, developmental issues, and perinatal history.
Main Results:
- The cohort included 10 boys and 1 girl with a median age of 2.5 years.
- Nine patients had PLP1 gene duplications; one had a point mutation, and one had a deletion.
- Common findings included nystagmus, hypotonia progressing to spasticity (more in legs), ataxia, and expressive speech difficulties. Feeding and sleep problems were also noted.
Conclusions:
- PMD presents with consistent neurological and speech impairments, influenced by PLP1 gene mutations.
- Perinatal complications were reported in many families.
- Further research is needed to understand genotype-phenotype variability in Pelizaeus-Merzbacher disease.